In Depth

Sustained interest? Biopharma’s green manufacturing gains traction

Bioproduction Booms: How innovation is redefining biologics, vaccines and therapeutics

From Nobel to next- gen: Sweden’s quiet life sciences ascent

ESMO25: Keytruda combo defies doubt, delivers PFS and OS gains in ovarian cancer

‘The time of the Einsteins is over’: Pharma urged to rethink trials for 2050

Biopharmaceutical industry cold-chain networks an innovation hotbed